PillEmtricitabine
Brands: Emtriva · Emtricitabine
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | unknown | 3 | SUPPLYING |
| Cipla USA Inc. | unknown | 2 | SUPPLYING |
| Gilead Sciences, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 17, 2026RESOLVEDShortage resolved: Emtricitabine Oral Solution (Gilead Sciences, Inc.)
Emtricitabine Oral Solution — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
- Jun 17, 2026SHORTAGEDrug shortage: Emtricitabine Oral Solution (Gilead Sciences, Inc.)
Emtricitabine Oral Solution — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
- Jun 17, 2026RESOLVEDShortage resolved: Emtricitabine Capsule (Gilead Sciences, Inc.)
Emtricitabine Capsule — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
- Jun 17, 2026SHORTAGEDrug shortage: Emtricitabine Capsule (Gilead Sciences, Inc.)
Emtricitabine Capsule — reported in shortage by Gilead Sciences, Inc.. Therapeutic category: Anti-Infective.
- Oct 1, 2014RECALLRecall (Class II): Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foste…
Defective Container; leaking around the cap — Recalling firm: Gilead Sciences, Inc. — United States, Puerto Rico, Fiji.